PRISM BioLab Co.,LTD (TYO:206A)
Japan · Delayed Price · Currency is JPY 169.00
+1.00 (0.60%)
Aug 27, 2026, 2:39 PM JST
PRISM BioLab Co.,LTD Balance Sheet
Financials in millions JPY. Fiscal year is October - September.
Millions JPY. Fiscal year is Oct - Sep.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Cash & Equivalents | 2,331 | 2,916 | 4,392 | 1,134 | 1,687 |
Cash & Short-Term Investments | 2,331 | 2,916 | 4,392 | 1,134 | 1,687 |
Cash Growth | -29.43% | -33.62% | 287.32% | -32.78% | - |
Accounts Receivable | 6.09 | - | - | - | 21 |
Other Receivables | 19.99 | 52.83 | 54.89 | 40.25 | - |
Receivables | 26.08 | 52.83 | 54.89 | 40.25 | 21 |
Prepaid Expenses | 47.68 | 54.41 | 29.22 | 17.93 | 14 |
Other Current Assets | 23.89 | 16.08 | 6.96 | 5.48 | 10 |
Total Current Assets | 2,429 | 3,039 | 4,483 | 1,198 | 1,732 |
Property, Plant & Equipment | - | 0 | - | 0 | - |
Long-Term Investments | - | - | - | - | 8 |
Other Long-Term Assets | 45.58 | 46.8 | 45.47 | 13.82 | - |
Total Assets | 2,474 | 3,086 | 4,529 | 1,211 | 1,740 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Accounts Payable | 68.72 | 78.72 | 57.68 | 38.6 | - |
Accrued Expenses | 30.34 | 21.17 | 8.28 | 5.06 | 2 |
Current Income Taxes Payable | 13.54 | 25.96 | 48.07 | 1.21 | 54 |
Current Unearned Revenue | 455.36 | 236.59 | 900.07 | 13.16 | - |
Other Current Liabilities | 8.7 | 7.64 | 5.78 | 5.21 | 9 |
Total Current Liabilities | 576.66 | 370.08 | 1,020 | 63.24 | 65 |
Other Long-Term Liabilities | 6.81 | 6.78 | 5.8 | 0.17 | 1 |
Total Liabilities | 583.47 | 376.86 | 1,026 | 63.41 | 66 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Common Stock | 1,740 | 1,731 | 1,714 | 12.25 | 12 |
Additional Paid-In Capital | 3,356 | 3,347 | 3,331 | 1,629 | 1,628 |
Retained Earnings | -3,222 | -2,376 | -1,543 | -493.22 | 33 |
Comprehensive Income & Other | 16.96 | 7.12 | 0.42 | 0.42 | 1 |
Shareholders' Equity | 1,891 | 2,709 | 3,503 | 1,148 | 1,674 |
Total Liabilities & Equity | 2,474 | 3,086 | 4,529 | 1,211 | 1,740 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Net Cash (Debt) | 2,331 | 2,916 | 4,392 | 1,134 | 1,687 |
Net Cash Growth | -29.43% | -33.62% | 287.32% | -32.78% | - |
Net Cash Per Share | 63.18 | 79.81 | 140.30 | 41.08 | 61.68 |
Filing Date Shares Outstanding | 36.96 | 36.92 | 31.3 | 31.35 | 27.35 |
Total Common Shares Outstanding | 36.96 | 36.81 | 31.3 | 31.35 | 27.35 |
Working Capital | 1,852 | 2,669 | 3,463 | 1,134 | 1,667 |
Book Value Per Share | 51.15 | 73.59 | 111.90 | 36.61 | 61.21 |
Tangible Book Value | 1,891 | 2,709 | 3,503 | 1,148 | 1,674 |
Tangible Book Value Per Share | 51.15 | 73.59 | 111.90 | 36.61 | 61.21 |
Buildings | 23.94 | 23.43 | 20.42 | 0.13 | - |
Machinery | 358.12 | 330.53 | 254.12 | 64.69 | - |